Elevated Serum Leptin Levels: A Risk Factor for Non-Small-Cell Lung Cancer?

Publisher： Karger

E-ISSN： 1423-0232|76|1|19-25

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.1, 2008-11, pp. : 19-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Serum Sialyl Lewis X-i Antigen Levels in Non-Small Cell Lung Cancer with Lung Metastasis

By  

Respiration, Vol. 65, Iss. 4, 1998-09 ,pp. : 295-298

Karger

Access to resources Recommend Favorite

Molecular Pathology of Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 72, Iss. 3, 2005-06 ,pp. : 313-330

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

The expression of astrocyte elevated gene‐1 in human non‐small‐cell lung cancer and its relationship with postoperative chemotherapy and radiotherapy

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 817-826

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancer

By Akerley Wallace L.   Nelson Richard E.   Cowie Robin H.   Spinella Dominic G.   Hornberger John  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 517-525

Informa Healthcare

Access to resources Recommend Favorite